E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 23-28)
DOI: 10.4318/tjg.2010.0043
Anadoluda anne ve bebeklerinde Helikobakter pilori enfeksiyonu
(Turk J Gastroenterol 2010; 21: 113-118)
DOI: 10.4318/tjg.2010.0067
Sequential therapy for Helicobacter pylori eradication
(Turk J Gastroenterol 2010; 21: 206-211)
DOI: 10.4318/tjg.2010.0089
Efficacy of probiotics in Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2010; 21: 212-217)
DOI: 10.4318/tjg.2010.0090
Effectiveness of different treatment regimens in helicobacter pylori eradication: Ten-year experience of a single institution
(Turk J Gastroenterol 2010; 21: 218-223)
DOI: 10.4318/tjg.2010.0091
Delta infection among children with cronic viral hepatitis
(Turk J Gastroenterol 1998; 9: 21-23)
Risk of Helicobacter pylori infection in newborn babies of Helicobacter pylori-positive pregrant woman
(Turk J Gastroenterol 1998; 9: 36-39)
One-week triple her therapies for Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 40-45)
Duodenal ulcer healing with one week therapy
(Turk J Gastroenterol 1998; 9: 46-49)
Helicobacter pylori and cobalamin deficiency
(Turk J Gastroenterol 1998; 9: 126-132)
The role of gastric juice ammonia and gastric huice urea nitrogen/ammonia in the diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 1998; 9: 133-137)
Helicobacter pylori seroprevalence in children, aged 6 months to 5 years old, in Turkey
(Turk J Gastroenterol 1998; 9: 138-145)
Recurrence rates after Helicobacter pylori eradication
(Turk J Gastroenterol 1998; 9: 154-158)
The type and localization of gastritis in patients with dudenal ulcer and relationship to helicobacter pylori
(Turk J Gastroenterol 1998; 9: 167-171)
Seroprevalence of anti-Helicobacter pylori and anti-CagA antibodies among healthy children according to age, sex, ABO blood groups and Rh status in south-east of Iran
(Turk J Gastroenterol 2007; 18: 165-171)
Seroprevalence of Helicobacter pylori in children with constitutional height retardation
(Turk J Gastroenterol 2006; 17: 7-12)
Fasciola hepatica infection: Clinical and computerized tomographic findings of ten patients
(Turk J Gastroenterol 2006; 17: 40-45)
The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients
(Turk J Gastroenterol 2006; 17: 79-83)
PCNA expression in chronic gastritis due to Helicobacter pylori*
(Turk J Gastroenterol 2006; 17: 84-89)
Bismuth-based therapies for the first step eradication of Helicobacter pylori
(Turk J Gastroenterol 2006; 17: 90-93)
Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis
(Turk J Gastroenterol 2006; 17: 172-176)
Importance of Helicobacter pylori in the etiology of chronic abdominal pain
(Turk J Gastroenterol 1999; 10: 24-26)
Efficacy of combination therapy with omeprazole, amoxicillin and clarithromycin for treatment of patients with Helicobacter pylori associated gastritis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 27-31)
Evaluation of chronic gastritis in patients with Helicobacter pylori associated gastritis, gastroduodenitis and duodenal ulcer disease
(Turk J Gastroenterol 1999; 10: 32-35)
Helicobacter pylori infection in gastric carcinoma in the Van region of Turkey
(Turk J Gastroenterol 1999; 10: 36-39)
Chronic hepatitis delta virus infection in Van region of eastern Turkey
(Turk J Gastroenterol 2005; 16: 17-20)
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
(Turk J Gastroenterol 2005; 16: 29-33)
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases
(Turk J Gastroenterol 2005; 16: 203-206)
The effect of different dosage and duration of lansoprazole-clarithromycin- amoxycillin combination on Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 115-117)
Changes in the degree of gastritis during the treatment of duodenal ulcer
(Turk J Gastroenterol 1999; 10: 118-121)
Seroepidemiology of delta hepatitis in Turkey
(Turk J Gastroenterol 1999; 10: 316-327)
The relationship between cagA positivity and serum gastrin and TNF- alpha levels in patients with chronic active gastritis and duodenal ulcer associated with Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 385-390)
Gastro-esophageal reflux following Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 411-418)
Intragastric distribution of Helicobacter pylori after eradication therapy
(Turk J Gastroenterol 2000; 11: 20-24)
A comparison of lansoprazole and omeprazole based triple combinations for the treatment of Helicobacter pylori associated gastritis and peptic ulcer
(Turk J Gastroenterol 2000; 11: 25-29)
Hydrops of the gallbladder associated with infection: A report of two cases
(Turk J Gastroenterol 2000; 11: 84-87)
Helicobacter pylori and antibiotic resistance
(Turk J Gastroenterol 2000; 11: 141-145)
The effect of CagA status on response to Helicobacter pylori eradication therapy
(Turk J Gastroenterol 2000; 11: 146-149)
The clinical role of stool test (HpSA) in noninvasive diagnosis of Helicobacter pylori infection
(Turk J Gastroenterol 2000; 11: 97-102)
Systemic cellular immune response in Helicobacter pylori associated duodenal ulcer and chronic antral gastritis
(Turk J Gastroenterol 2000; 11: 208-211)
Re-bleeding in patients following Helicobacter pylori eradication therapy for bleeding peptic ulcer:Results of 18 month-follow up
(Turk J Gastroenterol 2000; 11: 212-215)
The effects of alcohol on gastric mucosa and gastric emptying time
(Turk J Gastroenterol 2000; 11: 216-221)
Colonization of Helicobacter pylori–like organisms on the ectopic gastric mucosa of Meckel’s diverticulum:A case report*
(Turk J Gastroenterol 2000; 11: 264-266)
Effect of interferon treatment on glucose metabolism in children with chronic hepatitis B infection
(Turk J Gastroenterol 2004; 15: 4-10)
The mutations in ISDR of NS5A gene are not associated with response to interferon treatment in Turkish patients with chronic hepatitis C virus genotype lb infection
(Turk J Gastroenterol 2004; 15: 21-26)
Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum?
(Turk J Gastroenterol 2004; 15: 86-89)
Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy
(Turk J Gastroenterol 2004; 15: 90-93)
Acute abdomen caused by a ruptured spontaneously infected mesenteric cyst
(Turk J Gastroenterol 2004; 15: 120-121)
Lichen planus and HCV infection in Turkish patients
(Turk J Gastroenterol 2004; 15: 133-136)
The relation of Helicobacter pylori with intestinal metaplasia, gastric atrophy and BCL-2
(Turk J Gastroenterol 2004; 15: 149-155)
*Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years in Turkey
(Turk J Gastroenterol 2004; 15: 156-158)
The effect of Helicobacter pylori eradication in patients with functional dyspepsia: Assessment of different diagnostic tests
(Turk J Gastroenterol 2004; 15: 159-163)
Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha
(Turk J Gastroenterol 2004; 15: 213-218)
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori
(Turk J Gastroenterol 2004; 15: 219-224)
Predictive value of tissue cagA status in Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 27-31)
Can resistant Helicobacter pylori infection be estimated histologically: Effects of gastric histology on eradication rates of Helicobacter pylori infection
(Turk J Gastroenterol 2001; 12: 126-129)
Effects of Helicobacter pylori and liver cirrhosis on gastric mucosal hexosamine concentrations
(Turk J Gastroenterol 2001; 12: 206-210)
Does Helicobacter pylori infection have a role in coronary artery disease?
(Turk J Gastroenterol 2001; 12: 287-293)
The coexistence of sarcoidosis and hepatitis C: A case report
(Turk J Gastroenterol 2001; 12: 314-316)
Determination of primary resistance of Helicobacter pylori isolates to clarithromycin and amoxicilin by disc difussion method and the comparison with resistance in recurrent cases
(Turk J Gastroenterol 1997; 8: 309-312)
The association of Helicobacter Pylori with gastric epithelial cell proliferation
(Turk J Gastroenterol 1998; 9: 349-353)
The comparsion of lansoprazole and omeprazole in the one-week triple therapy for the eradication of Helicobacter Pylori
(Turk J Gastroenterol 1998; 9: 354-357)
Low prevalence of erosive esophagitis and Barrett esophagus in a tertiary referral center in Turkey
(Turk J Gastroenterol 2008; 19: 146-151)
The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: An open-label pilot study
(Turk J Gastroenterol 2008; 19: 158-162)
Detection of point mutations on 23S rRNA of Helicobacter pylori and resistance to clarithromycin with PCR-RFLP in gastric biopsy specimens in Mersin, Turkey
(Turk J Gastroenterol 2008; 19: 163-167)
Detection of Helicobacter pylori using nested polymerase chain reaction and rapid urease test in gastric biopsy samples
(Turk J Gastroenterol 2002; 13: 94-97)
The relationship between Helicobacter pylori intensity and histopathological findings in cases with chronic gastritis and duodenal ulcer
(Turk J Gastroenterol 2002; 13: 98-102)
The prevalence of manifest and latent celiac disease in type 1 diabetes mellitus
(Turk J Gastroenterol 2002; 13: 103-107)
The effect of Helicobacter pylori eradication on symptoms and gastric emptying in patients with nonulcer dyspepsia
(Turk J Gastroenterol 2002; 13: 146-153)
Relationship between gastritis severity, Helicobacter pylori intensity and mast cell density in the antrum and corpus
(Turk J Gastroenterol 2002; 13: 154-158)
Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors?
(Turk J Gastroenterol 2002; 13: 159-163)
The association of short segment Barrett's esophagus with intestinal metaplasia in stomach
(Turk J Gastroenterol 2003; 14: 33-38)
The researched of Helicobacter pylori incidence on Turkish population who have been living in Germany
(Turk J Gastroenterol 1996; 7: 61-64)
Benzathine penicilin G in prophylaxis of Helicobacter pylori infection
(Turk J Gastroenterol 1996; 7: 65-68)
An effective and economic approach for the eradication of Helicobacter Pylori:omeprazole and two antibiotic combination
(Turk J Gastroenterol 1996; 7: 228-232)
Prevelance of Helicobacter pylori in patients with of without dyspepsia and comparsion of different methods in the diagnosis of helicobacter pylori
(Turk J Gastroenterol 1996; 7: 223-236)
Prevelance of helicobacter pylori infection among Turkish living in or near Stutgart Germany, and the effect of triple therapy (pantoprazole-clarithomycin-metronidzole) on Helicobacter pylori infection
(Turk J Gastroenterol 1996; 7: 237-239)
Chronic hepatitis C with mixed cryoglubulinemia: A cade report
(Turk J Gastroenterol 1996; 7: 254-256)
The effect of eradaicating helicobacter pylori infection on intragastric pH and serum gastrin concentrations
(Turk J Gastroenterol 1996; 7: 331-334)
Dietary nitrate and nitrite levels in an endemic upper gastrointestinal (esophageal and gastric) cancer region of Turkey
(Turk J Gastroenterol 2003; 14: 50-53)
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: Clinical significance and correlation with serological markers
(Turk J Gastroenterol 2003; 14: 157-163)
Expression of class I and II MHC receptors in Helicobacter pylori-positive patients with active gastritis and duodenal ulcer*
(Turk J Gastroenterol 2003; 14: 168-172)
The effect of duodenogastric reflux on Helicobacter pylori presence and gastric histopathologic changes
(Turk J Gastroenterol 2003; 14: 239-242)
HDV infection in liver cirrhosis
(Turk J Gastroenterol 1996; 7: 1-5)
Hepatitis C virus infection in hemodialysis or continuous ambutory peritoneal dialysis pateients: result of comparivate analysis
(Turk J Gastroenterol 1997; 8: 21-27)
Prevelance of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 1997; 8: 66-70)
Effect of omeprazole, claritomycine and amoxiciline therapy on duodenal ulcer and Helicobacter pylori eradication
(Turk J Gastroenterol 1997; 8: 71-73)
The prevalence of lymphoid follicles and intestinal metaplasia in Helicobacter pylori associated clinically significant gastroduodenal diseases
(Turk J Gastroenterol 1999; 10: 197-201)
Ranitidine bismuth citrate based dual and triple therapies in Helicobacter pylori eradication
(Turk J Gastroenterol 1999; 10: 202-206)
Nitric oxide oxidation products in the serum of patients with gastric and esophageal cancer and Helicobacter pylori
(Turk J Gastroenterol 1999; 10: 193-196)
Blind gastric biopsy in the diagnosis of Helicobacter Pylori infection
(Turk J Gastroenterol 1997; 8: 440-442)
Surgical management of perforated dudenal ulcers
(Turk J Gastroenterol 1997; 8: 447-453)
The importance of Candida in a cade with refactory duodenal ulcer
(Turk J Gastroenterol 1997; 8: 251-253)
Review
Clostridium difficile infection and inflammatory bowel disease
(Turk J Gastroenterol 2014; 25: 603-610)
DOI: 10.5152/tjg.2014.14054
A proposed role for diffusible signal factors in the biofilm formation and morphological transformation of Helicobacter pylori
(Turk J Gastroenterol 2018; 29: 7-13)
DOI: 10.5152/tjg.2017.17349
Gastroesophageal reflux disease and the relationship with Helicobacter pylori
(Turk J Gastroenterol 2017; 28: 61-67)
DOI: 10.5152/tjg.2017.16
Case Report
A case of endoscopic ultrasound diagnosis of gastric amyloidosis
(Turk J Gastroenterol 2012; 23: 769-772)
DOI: 10.4318/tjg.2012.0443
Definition of C282Y mutation in a hereditary hemochromatosis family from Turkey
(Turk J Gastroenterol 2007; 18: 53-57)
Gastric infection by Strongyloides stercoralis: A case report
(Turk J Gastroenterol 2009; 20: 48-51)
Original Article
Helicobacter pylori and histopathological findings in patients with dyspepsia
(Turk J Gastroenterol 2011; 22: 122-127)
DOI: 10.4318/tjg.2011.0179
Evaluation of serum ghrelin levels in patients with hyperplastic gastric polyps
(Turk J Gastroenterol 2012; 23: 444-447)
DOI: 10.4318/tjg.2012.0424
Assessment of COX-2 expression presence and severity by immunohistochemical method in patients with chronic active gastritis and intestinal metaplasia
(Turk J Gastroenterol 2012; 23: 478-484)
DOI: 10.4318/tjg.2012.0432
Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients
(Turk J Gastroenterol 2012; 23: 552-559)
DOI: 10.4318/tjg.2012.0410
The assessment of carotid intima-media thickness, lipid profiles and oxidative stress markers in Helicobacter pylori-positive subjects
(Turk J Gastroenterol 2012; 23: 646-651)
DOI: 10.4318/tjg.2012.0441
Does Helicobacter pylori treatment improve the symptoms of globus hystericus?
(Turk J Gastroenterol 2012; 23: 681-685)
DOI: 10.4318/tjg.2012.0507
The diagnostic accuracy of urine IgG antibody tests for the detection of Helicobacter pylori infection in Turkish dyspeptic patients
(Turk J Gastroenterol 2012; 23: 753-758)
DOI: 10.4318/tjg.2012.0497
Investigation of ErbB-2 Overexpression on Patients with Gastric Cancer in Eastern Anatolia of Turkey
(Turk J Gastroenterol 2013; 24: 211-217)
DOI: 10.4318/tjg.2013.0641
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazolebased triple therapy for the eradication of Helicobacter pylori in dyspeptic patients
(Turk J Gastroenterol 2013; 24: 316-321)
DOI: 10.4318/tjg.2013.0509
Ornidazole-based sequential therapy is not effective in Helicobacter pylori eradication in children
(Turk J Gastroenterol 2013; 24: 382-386)
DOI: 10.4318/tjg.2013.0575
Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China
(Turk J Gastroenterol 2013; 24: 5-9)
DOI: 10.4318/tjg.2013.0525
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial
(Turk J Gastroenterol 2013; 24: 10-14)
DOI: 10.4318/tjg.2013.0540
Ongoing symptoms after eradication of Helicobacter pylori: Psychiatric disorders may accompany!
(Turk J Gastroenterol 2013; 24: 15-21)
DOI: 10.4318/tjg.2013.0582
The impact of hepatitis C virus infection on long-term outcome in renal transplant patients
(Turk J Gastroenterol 2011; 22: 165-170)
DOI: 10.4318/tjg.2011.0236
A retrospective study demonstrating properties of nonvariceal upper gastrointestinal bleeding in Turkey
(Turk J Gastroenterol 2011; 22: 249-254)
DOI: 10.4318/tjg.2011.0209
The role of interleukin-1 gene polymorphisms and Helicobacter pylori in gastroesophageal reflux disease
(Turk J Gastroenterol 2014; 25: 81-85)
DOI: 10.5152/tjg.2014.6512
Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children
(Turk J Gastroenterol 2014; 25: 99-103)
DOI: 10.5152/tjg.2014.5592
Analysis of cases with tuberculous peritonitis: A single-center experience
(Turk J Gastroenterol 2014; 25: 72-78)
DOI: 10.5152/tjg.2014.5145
Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients
(Turk J Gastroenterol 2011; 22: 569-574)
DOI: 10.4318/tjg.2011.0252
Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin
(Turk J Gastroenterol 2011; 22: 582-586)
DOI: 10.4318/tjg.2011.0255
Is there a relationship between Helicobacter pylori and gastric autoimmunity?
(Turk J Gastroenterol 2011; 22: 134-138)
DOI: 10.4318/tjg.2011.0181
Helicobacter pylori infection and administration of non-steroidal anti-inflammatory drugs down-regulate the expression of gastrokine-1 in gastric mucosa
(Turk J Gastroenterol 2012; 23: 212-219)
DOI: 10.4318/tjg.2012.0345
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori
(Turk J Gastroenterol 2012; 23: 8-13)
DOI: 10.4318/tjg.2012.0392
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease
(Turk J Gastroenterol 2011; 22: 1-5)
DOI: 10.4318/tjg.2011.0148
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance
(Turk J Gastroenterol 2017; 28: 3-11)
DOI: 10.5152/tjg.2016.0278
Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection
(Turk J Gastroenterol 2015; 26: 456-460)
DOI: 10.5152/tjg.2015.0233
Effect of pantoprazole and Helicobacter pylori therapy on uninvestigated dyspeptic patients
(Turk J Gastroenterol 2015; 26: 6-14)
DOI: 10.5152/tjg.2015.0010
Is there any association between colonic polyps and gastric intestinal metaplasia?
(Turk J Gastroenterol 2016; 27: 221-226)
DOI: 10.5152/tjg.2016.15212
Decreasing prevalence of Helicobacter pylori according to birth cohorts in urban China
(Turk J Gastroenterol 2017; 28: 94-97)
DOI: 10.5152/tjg.2017.16557
Relationship between Helicobacter pylori infection and metabolic syndrome
(Turk J Gastroenterol 2015; 26: 468-473)
DOI: 10.5152/tjg.2015.0197
The importance of upper gastrointestinal endoscopy in morbidly obese patients
(Turk J Gastroenterol 2015; 26: 228-231)
DOI: 10.5152/tjg.2015.0083
Cirrhotic Ascites management via procalcitonin level and a new approach B-mode gray-scale histogram
(Turk J Gastroenterol 2016; 27: 47-54)
DOI: 10.5152/tjg.2015.150345
Seroprevalence of human fascioliasis in Van province, Turkey
(Turk J Gastroenterol 2015; 26: 259-262)
DOI: 10.5152/tjg.2015.8001
Incidence, causes, and outcomes of renal failure among cirrhotic patients
(Turk J Gastroenterol 2015; 26: 517-521)
DOI: 10.5152/tjg.2015.15169
Gastrointestinal Tract - Original Article
Standard triple therapy in Helicobacter pylori eradication in Turkey: Systematic evaluation and meta-analysis of 10-year studies
(Turk J Gastroenterol 2019; 30: 420-435)
DOI: 10.5152/tjg.2019.18693
Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer
(Turk J Gastroenterol 2019; 30: 15-20)
DOI: 10.5152/tjg.2018.17461
Combined treatment for gastric cancer: Immunological approach
(Turk J Gastroenterol 2018; 29: 151-156)
DOI: 10.5152/tjg.2018.17398
Role of toll-like receptor 10 gene polymorphism and gastric mucosal pattern in patients with chronic gastritis
(Turk J Gastroenterol 2017; 28: 243-247)
DOI: 10.5152/tjg.2017.16673
Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples
(Turk J Gastroenterol 2018; 29: 157-163)
DOI: 10.5152/tjg.2018.17568
Does Helicobacter pylori infection influence the major postoperative complication rate after sleeve gastrectomy? A retrospective cohort study in an endemic region
(Turk J Gastroenterol 2018; 29: 379-383)
DOI: 10.5152/tjg.2018.17373
The evaluation of the effect of Helicobacter pylori infection on choroidal thickness
(Turk J Gastroenterol 2018; 29: 636-641)
DOI: 10.5152/tjg.2018.17557
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study
(Turk J Gastroenterol 2018; 29: 549-554)
DOI: 10.5152/tjg.2018.17707
Association of a single nucleotide polymorphism in the TLR2 gene (rs3804099), but not in the TLR4 gene (rs4986790), with Helicobacter pylori infection and peptic ulcer
(Turk J Gastroenterol 2018; 29: 283-291)
DOI: 10.5152/tjg.2018.17484
Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand
(Turk J Gastroenterol 2018; 29: 555-560)
DOI: 10.5152/tjg.2018.17608
Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and İzmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program
(Turk J Gastroenterol 2018; 29: 36-44)
DOI: 10.5152/tjg.2018.17263
Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk
(Turk J Gastroenterol 2018; 29: 427-435)
DOI: 10.5152/tjg.2018.17350
Toll-like receptor 2 and 4 polymorphisms associated with Helicobacter pylori susceptibility and gastric cancer
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17461
The evaluation of the effect of Helicobacter pylori infection on choroidal thickness
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17557
Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17350
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17707
Role of screening colonoscopy for colorectal tumors in Helicobacter pylori-related chronic gastritis with MDM2 SNP309 G/G homozygous: A prospective cross-sectional study in Thailand
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17608
Does Helicobacter pylori infection influence the major postoperative complication rate after sleeve gastrectomy? A retrospective cohort study in an endemic region
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.17373
Liver - Original Article
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol 2019; 30: 66-74)
DOI: 10.5152/tjg.2018.18148
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol 2018; 29: 464-472)
DOI: 10.5152/tjg.2018.16597
Lamivudine’s efficacy and safety in preventing mother-to-child transmission of hepatitis B: A meta-analysis
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.18148
Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study
(Turk J Gastroenterol ; : -)
DOI: 10.5152/tjg.2018.16597
Pediatric Gastroenterology - Original Article
Helicobacter pylori prevalence and risk factors among children with celiac disease
(Turk J Gastroenterol 2019; 30: 284-289)
DOI: 10.5152/tjg.2018.18181
Prevalence of celiac disease among school-age children in Çorum, Turkey
(Turk J Gastroenterol 2018; 29: 595-600)
DOI: 10.5152/tjg.2018.18020
Poster
Retrospective Investigation of De novo hepatitis B infection in recipients after liver transplantation by anti-HBc positive donors
(Turk J Gastroenterol 2019; 30: 20-20)
DOI: 10.5152/tjg.2019.10
A case of acute toxic hepatitis associated with Prangos ferulacea
(Turk J Gastroenterol 2019; 30: 23-23)
DOI: 10.5152/tjg.2019.12
Wild mushroom poisoning in Mersin: A retrospective epidemiological study and investigation of liver toxicity
(Turk J Gastroenterol 2019; 30: 24-24)
DOI: 10.5152/tjg.2019.13
A real-life evaluation of the effect of direct-acting antivirals in hemodialysis patients with chronic hepatitis C
(Turk J Gastroenterol 2019; 30: 39-40)
DOI: 10.5152/tjg.2019.25
The under water part of the iceberg: Anti-HCV positivity
(Turk J Gastroenterol 2019; 30: 48-49)
DOI: 10.5152/tjg.2019.31
HBsAg seroclearance in the chronic hepatitis B patients whom naïve and nucleos(t)ide analogue-treated: a long-term follow-up study
(Turk J Gastroenterol 2019; 30: 50-50)
DOI: 10.5152/tjg.2019.32
Acute liver ınjury in a patient with secondary syphilis and acute viral hepatitis B coinfection
(Turk J Gastroenterol 2019; 30: 75-75)
DOI: 10.5152/tjg.2019.50
Poster Presentation
The importance of HBV testing during pregnancy and immunization and current HBV situation of babies
(Turk J Gastroenterol 2019; 30: 97-99)
DOI: 10.5152/tjg.2019.64
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 09.05.2019